Navigation Links
Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
Date:9/20/2012

ALISO VIEJO, Calif., Sept. 20, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced several business updates. The highlights are being provided in connection with the company's presentation today at the UBS Global Life Sciences Conference in New York City.

Highlights include:

  • Exceeding 10,000 total NUEDEXTA® prescriptions for the month of August.
    • NUEDEXTA prescriptions of 10,710 in August represent 9% growth over the month of July.
    • August monthly prescriptions annualize to a gross NUEDEXTA sales run-rate of over $65 million.
    • Achieved record weekly prescriptions of 2,552 for the week-ending September 7, 2012
  • Presentation of interim PRISM Registry data at the 16th Congress of the European Federation of Neurological Societies (EFNS) in Stockholm Sweden. Dr. Jonathan Fellus' presentation entitled The PRISM Registry: A Novel Research Tool to Estimate the Prevalence of Pseudobulbar Affect highlighted data showing that of the 4,349 enrolled patients, approximately 37% of all participants had PBA symptoms as measured by a CNS-LS score ≥13.
  • Strong interest and robust recruitment in the AVP-923 phase II clinical study of agitation in Alzheimer's disease demonstrated across eight sites currently recruiting patients.*
  • Recent submission of responses to the European Medicines Agency (EMA) for the NUEDEXTA Marketing Authorization Application (MAA). The submitted responses address the "Day-120" questions posed by the EMA in March 2012. Based on the review timelines, Avanir expects to receive an opinion from the Committee for Medicinal Products for Human Use (CHMP) regarding the NUEDEXTA MAA by the first calendar quarter of 2013.

A live webcast and 30-day archive of the presentatio
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals To Present at Three Conferences In May
2. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
3. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
4. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
5. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
6. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
7. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
8. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... TEL AVIV, Israel , March 30, 2015   ... , announced the closing of $12.5 million in new financing ... the Viola Group. The funding will further GlassesUSA,s aggressive business ... the growing global market of online eyewear, both B2C and ... Daniel Rothman , COO Eldad Rothman , and ...
(Date:3/30/2015)... 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... ("EC") has conditionally cleared Zimmer,s proposed acquisition of ... upon Zimmer entering into agreements with a suitable ... package previously submitted to the EC.  Zimmer expects ... term.  As previously announced, the proposed transaction also ...
(Date:3/30/2015)... , March 30, 2015  The future ... to involve more data analytics; new, more precise ... imaging and motion management techniques.  Some 150 researchers ... ideas last week at a symposium on research ... ).     "Researchers are developing, testing, ...
Breaking Medicine Technology:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 2Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 4Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 4Radiation Oncology Researchers Glimpse the Future of Cancer Care 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 6
(Date:3/30/2015)... Northridge, CA (PRWEB) March 30, 2015 ... special promotion on Invisalign. Eligible patients will receive $200 ... but are not particularly interested in wearing a mouthful ... Arami’s team, “The use of traditional braces is effective ... people who are already concerned with their oral appearance. ...
(Date:3/30/2015)... an app from the makers of Mega Photo, launched ... and simplicity of photo slideshows. The extremely user-friendly app ... instantly share them across their Facebook, Twitter, and Instagram ... slideshow app where users can share their own photo ... them. You can choose your own effects or we ...
(Date:3/30/2015)... The “Orthopedic Software Market ... PACS) By Applications (Orthopedic Surgery, Joint Replacement, ... Delivery] – Global Forecast to 2020” analyzes ... opportunities in North America, Europe, Asia-Pacific and ... Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 , ...
(Date:3/30/2015)... Daily sun exposure, stressors and environmental ... wrinkles, folds and other giveaways of age. However, advances ... women to hit the pause button, delaying the impact ... tuck or hack to rejuvenate any facial feature. , ... Surgery (AAFPRS) explores the intricacies of The Aging ...
(Date:3/30/2015)... A new recruitment site has been launched ... next career move. , Millions of new jobs are ... with skills in the booming data and analytics sectors.* ... jobs aggregator, pulling in opportunities from both employers and ... to help candidates find suitable big data and analytics ...
Breaking Medicine News(10 mins):Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4Health News:New AAFPRS Infographic Addresses Concerns and Provides Aging Face Solutions 2Health News:New Global Job Site Launched for Big Data and Analytics Job Seekers 2
... improve prognosis for cardiac disease, researchers say , ... Internet-based interventions may help heart attack survivors and ... reduce their risk of future cardiac events, Australian ... evaluating the use of phone- or Internet-based interventions ...
... branch of the human immune system have interconnected has ... a central component of an enzyme important to the ... system fights invading microbes while avoiding problems of the ... way to more efficient therapeutics for such complement-mediated diseases ...
... the scientific symposium of the Cardiovascular Research Foundation, will ... trial data in the field of percutaneous coronary intervention ... to attend TCT 2009 at www.tctconference.com . ... clinical trials and first report investigations will be highlighted ...
... ... strategic measurement during a seminar co-sponsored by the American Association of Port Authorities (AAPA) ... in Detroit. , ... Livingston, NJ (PRWEB) June 17, 2009-- BurrellesLuce Vice President Johna Burke will ...
... , ... Progressive Medical, Inc. ( www.progressive-medical.com ) announced ... top workplaces for information technology (IT) professionals. The Best Places to ... notes the best work environments for technology professionals. Progressive Medical, through ...
... for scanning breast tissue may help find what traditional mammography ... , Listen to this report from Siemens (NYSE: ... , , Registered journalists can access video, audio, ... http://www.mediaseed.tv . , , ...
Cached Medicine News:Health News:Calling All Heart Patients 2Health News:Structures from the human immune system's oldest branch shed light on a range of diseases 2Health News:Structures from the human immune system's oldest branch shed light on a range of diseases 3Health News:BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter 2Health News:BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter 3Health News:IDG's Computerworld Names Progressive Medical to Annual List of Best Places to Work in Information Technology 2Health News:IDG's Computerworld Names Progressive Medical to Annual List of Best Places to Work in Information Technology 3Health News:IDG's Computerworld Names Progressive Medical to Annual List of Best Places to Work in Information Technology 4
The Streck-MD-Pack is specially designed for use on Coulter® MD Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
A lytic reagent manufactured for the simultaneous quantitative determinations of hemoglobin and white blood cells. Streck-Lysing Agent III is for use on the Abbott CELL-DYN® 1400 and 1600. The sh...
Streck-Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3000. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Medicine Products: